187 related articles for article (PubMed ID: 25322783)
1. LC-MS/MS determination of apixaban (BMS-562247) and its major metabolite in human plasma: an application of polarity switching and monolithic HPLC column.
Pursley J; Shen JX; Schuster A; Dang OT; Lehman J; Buonarati MH; Song Y; Aubry AF; Arnold ME
Bioanalysis; 2014 Aug; 6(15):2071-82. PubMed ID: 25322783
[TBL] [Abstract][Full Text] [Related]
2. Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC-MS/MS method.
Zhang WL; Lou D; Zhang DT; Zhang Y; Huang HJ
J Thromb Thrombolysis; 2016 Aug; 42(2):205-11. PubMed ID: 27116356
[TBL] [Abstract][Full Text] [Related]
3. "Center punch" and "whole spot" bioanalysis of apixaban in human dried blood spot samples by UHPLC-MS/MS.
Zheng N; Yuan L; Ji QC; Mangus H; Song Y; Frost C; Zeng J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():66-74. PubMed ID: 25746754
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillation.
Skeppholm M; Al-Aieshy F; Berndtsson M; Al-Khalili F; Rönquist-Nii Y; Söderblom L; Östlund AY; Pohanka A; Antovic J; Malmström RE
Thromb Res; 2015 Jul; 136(1):148-53. PubMed ID: 25981142
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
[TBL] [Abstract][Full Text] [Related]
6. Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: application to pharmacokinetic study.
Delavenne X; Mismetti P; Basset T
J Pharm Biomed Anal; 2013 May; 78-79():150-3. PubMed ID: 23499913
[TBL] [Abstract][Full Text] [Related]
7. Sensitive and accurate liquid chromatography-tandem mass spectrometry methods for quantitative determination of a novel hepatitis C NS5B inhibitor BMS-791325 and its active metabolite in human plasma and urine.
Jiang H; Demers R; Kandoussi H; Burrell R; Eley T; Kadiyala P; Cojocaru L; Baker C; Ryan J; Aubry AF; Arnold ME; Zeng J
J Pharm Biomed Anal; 2015 Mar; 107():17-23. PubMed ID: 25562845
[TBL] [Abstract][Full Text] [Related]
8. A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.
Lagoutte-Renosi J; Le Poupon J; Girard A; Montange D; Davani S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():43-49. PubMed ID: 30292948
[TBL] [Abstract][Full Text] [Related]
9. Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma.
Jian W; Edom R; Weng N; Zannikos P; Zhang Z; Wang H
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1687-99. PubMed ID: 20462810
[TBL] [Abstract][Full Text] [Related]
10. Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma.
Baldelli S; Cattaneo D; Pignatelli P; Perrone V; Pastori D; Radice S; Violi F; Clementi E
Bioanalysis; 2016 Feb; 8(4):275-83. PubMed ID: 26808218
[TBL] [Abstract][Full Text] [Related]
11. Determination of olprinone in human plasma utilizing liquid chromatography tandem mass spectrometry.
Zhu P; Wen YG; Chen JM; Zhuang J; Zhou ZL; Zheng SY; Wu RB; Xiao XJ; Lu C; Fan RX; Guo HM; Fan XP
J Pharm Biomed Anal; 2011 Jan; 54(1):198-202. PubMed ID: 20728297
[TBL] [Abstract][Full Text] [Related]
12. Paramagnetic micro-particles as a tool for rapid quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma by UHPLC-MS/MS.
Wiesen MHJ; Blaich C; Streichert T; Michels G; Müller C
Clin Chem Lab Med; 2017 Aug; 55(9):1349-1359. PubMed ID: 28328524
[TBL] [Abstract][Full Text] [Related]
13. Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS-Method Development, Validation, and Application.
Lindahl S; Dyrkorn R; Spigset O; Hegstad S
Ther Drug Monit; 2018 Jun; 40(3):369-376. PubMed ID: 29578938
[TBL] [Abstract][Full Text] [Related]
14. Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study.
Gouin-Thibault I; Flaujac C; Delavenne X; Quenet S; Horellou MH; Laporte S; Siguret V; Lecompte T
Thromb Haemost; 2014 Feb; 111(2):240-8. PubMed ID: 24172843
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a gamma-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions.
Gu H; Deng Y; Wang J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2319-26. PubMed ID: 20674522
[TBL] [Abstract][Full Text] [Related]
16. Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma.
Jiang H; Kandoussi H; Zeng J; Wang J; Demers R; Eley T; He B; Burrell R; Easter J; Kadiyala P; Pursley J; Cojocaru L; Baker C; Ryan J; Aubry AF; Arnold ME
J Pharm Biomed Anal; 2015 Mar; 107():409-18. PubMed ID: 25676854
[TBL] [Abstract][Full Text] [Related]
17. Development of simple and rapid LC-MS/MS method for determination of celecoxib in human plasma and its application to bioequivalence study.
Park MS; Shim WS; Yim SV; Lee KT
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():137-41. PubMed ID: 22771234
[TBL] [Abstract][Full Text] [Related]
18. Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay.
Barrett YC; Wang Z; Frost C; Shenker A
Thromb Haemost; 2010 Dec; 104(6):1263-71. PubMed ID: 20978714
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Lu S; Jiang K; Qin F; Lu X; Li F
J Pharm Biomed Anal; 2009 Jan; 49(1):163-7. PubMed ID: 19046843
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
